Sign In

Simon Kerry

Experienced Business Leader in the Biotech Sector

Simon Kerry is a seasoned business professional with a rich background in creating and advancing innovative life science ventures over a span of 25 years.

Currently serving as an Operating Partner at Advent Life Sciences, Simon also holds the CEO positions at Curve Therapeutics Ltd and Encipher BioTherapeutics, showcasing his diverse leadership roles in the industry.

During his tenure as CEO of Karus Therapeutics from 2006 to 2017, Simon successfully steered the company from its initiation to a clinical-stage entity, highlighting his strategic vision and management capabilities.

His past experiences include pivotal roles such as Director of Business Development at Ablynx NV, where he forged significant partnerships with prominent pharmaceutical firms like Pfizer and Novartis, contributing to Ablynx's evolution into a key player in the antibody fragment sector.

Simon's career also encompasses stints as Director of Business Development at Active Biotech AB and various commercial positions at Actinova Ltd and Actigen Ltd, underscoring his versatile expertise in the life science domain.

With a solid educational foundation, Simon Kerry holds a Medicinal Chemistry degree, a PhD in Medicinal Chemistry and Microbiology, and an Executive MBA from Loughborough University Business School, reflecting his commitment to continuous learning and professional growth.

S
Add to my network

Location

London, Greater London, United Kingdom